We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The government introduced a ‘Cloud First’ policy in 2013 for all technology decisions.
This guidance outlines how to make informed choices about your organisation’s reliance on cloud technologies.
Descriptions of team capabilities on the Digital Outcomes and Specialists framework.
How organisations can renew or get a PSN service provision compliance certificate so they can use a current connection to provide a service to PSN customers.
A list of goods and services showing which rates of VAT apply and which items are exempt or outside the scope of VAT.
Lassa virus causes Lassa fever, an acute viral haemorrhagic fever (VHF).
There have been a small number of reports of serious and life-threatening anticholinergic side effects associated with hyoscine hydrobromide patches, particularly when used outside the licence.…
How to choose data tools and infrastructure that are flexible, scalable, sustainable and secure.
Keep systems and data safe with the appropriate level of security.
How to assess a planning application when there are reptiles on or near a proposed development site.
Medication errors and inappropriate use of the rivastigmine transdermal patch have been reported, some of which resulted in overdose. Healthcare professionals should be aware of the correct use of rivastigmine, and should advise patients and caregivers as outlined in this article.
Following a review of the risks associated with use of opioid medicines for non-cancer pain, the Commission on Human Medicines (CHM) has recommended that fentanyl transdermal patches are contraindicated in opioid-naive patients in the UK.…
MHRA has received reports of unintentional overdose of fentanyl due to dosing errors, accidental exposure, and exposure of the patch to a heat source.
…We continue to receive reports of unintentional opioid toxicity and overdose of fentanyl due to accidental exposure to patches.…
Get help to classify various types of wood for import and export.
Cold-chain storage and distribution system now been fully implemented by manufacturer.
We remind you to provide clear information to patients and caregivers regarding risk of accidental patch transfer and ingestion of patches, and need for appropriate disposal of patches.
Theramex has informed the MHRA that some cartons of Evorel Sequi contain the incorrect combination of patches. An error at the packaging site means that a limited number of packs have the incorrect combination of Evorel 50 and Evorel Conti patches.
Medicines have been taken out of the regulated medicines’ supply chain during distribution. The products have been parallel imported into the UK by Kosei Pharma, CST Pharma and Ordinant Medical Solutions from Italy and they …
Omega Pharma Limited have identified an error relating to the product packaging.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).